Favorable outcome of empagliflozin treatment in two pediatric glycogen storage disease type 1b patients

• मुख्य लेखकों: Zufit Hexner-Erlichman (लेखक), Maria Veiga- (लेखक), Yoav Zehavi (लेखक), Zahava Vadasz (लेखक), Adi D. Sabag (लेखक), Sameh Tatour (लेखक), Ronen Spiegel (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Frontiers Media S.A., 2022-11-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

BackgroundGlycogen storage disease type 1b (GSD1b) is an ultra-rare autosomal recessive disorder, caused by mutations in SLC37A4 gene. Affected patients present with episodes of fasting hypoglycemia and lactic acidosis, hepatomegaly, growth retardation, hyperlipidemia and renal impairment. In additi...